Somnath Mukhopadhyay
- Interactions between exposure to cigarette smoke and variations in the GSTM genotype for asthma quality of lifeBy Steve Turner, Roger Tavendale, Somnath Mukhopadhyay, Anil Mehta, Colin Palmer and Jon AyresSteve Turner1Child Health, University of Aberdeen, United KingdomRoger Tavendale2Population Pharmacogenetics Group, University of Dundee, United KingdomSomnath Mukhopadhyay3Division of Maternal & Child Health Sciences, University of Dundee, United KingdomAnil Mehta4Child Health, Brighton and Sussex Medical School, Brighton, United KingdomColin Palmer2Population Pharmacogenetics Group, University of Dundee, United KingdomJon Ayres5Occupational and Environmental Medicine, University of Birmingham, United Kingdom
- Interaction between the Arg16 homozygous genotype, inhaled corticosteroids and long acting beta agonists for asthma exacerbations in children? Leukotriene receptor antagonists to the rescue?By Steve Turner, Kaninika Basu, Lauren Bignell, Jon Ayres, Roger Tavendale, Brian Lipworth, Anil Mehta, Somnath Mukhopadhyay and Colin PalmerSteve Turner1Child Health, University of Aberdeen, Aberdeen, United KingdomKaninika Basu2Academic Department of Paediatrics, University of Brighton, Brighton, United KingdomLauren Bignell2Academic Department of Paediatrics, University of Brighton, Brighton, United KingdomJon Ayres3Institute of Occupational and Environmental Medicine, University of Birmingham, Birmingham, United KingdomRoger Tavendale4Population Pharmacogenetics Group, University of Dundee, Dundee, United KingdomBrian Lipworth4Population Pharmacogenetics Group, University of Dundee, Dundee, United KingdomAnil Mehta4Population Pharmacogenetics Group, University of Dundee, Dundee, United KingdomSomnath Mukhopadhyay2Academic Department of Paediatrics, University of Brighton, Brighton, United KingdomColin Palmer4Population Pharmacogenetics Group, University of Dundee, Dundee, United Kingdom
- LSC 2013 abstract - ST13 and ORMDL3 polymorphisms affect the risk of exacerbations in steroid-treated asthmatic children and young adultsBy Susanne Vijverberg, Ellen Koster, Roger Tavendale, Maarten Leusink, Leo Koenderman, Jan Raaijmakers, Dirkje Postma, Gerard Koppelman, Steve Turner, Somnath Mukhopadhyay, Sze Man Tse, Kelan Tantisira, Colin Palmer and Anke-Hilse Maitland-van der ZeeSusanne Vijverberg1Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, Netherlands3Department of Respiratory Medicine, University Medical Centre Utrecht, Utrecht, NetherlandsEllen Koster1Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, NetherlandsRoger Tavendale2Population Pharmacogenetics Group, Biomedical Research Institute, University of Dundee, Ninewells Hospital and Medical School, Dundee, United KingdomMaarten Leusink1Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, NetherlandsLeo Koenderman3Department of Respiratory Medicine, University Medical Centre Utrecht, Utrecht, NetherlandsJan Raaijmakers1Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, NetherlandsDirkje Postma4Department of Pulmonology, Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, NetherlandsGerard Koppelman5Department of Paediatric Pulmonology and Paediatric Allergology, Beatrix Children's Hospital, Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center, Groningen, NetherlandsSteve Turner6Department of Child Health, University of Aberdeen, Aberdeen, United KingdomSomnath Mukhopadhyay2Population Pharmacogenetics Group, Biomedical Research Institute, University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom8Department of Paediatrics, Royal Alexandra Children's Hospital, Brighton and Sussex Medical School, Brighton, United KingdomSze Man Tse7Department of Medicine, Brigham and Women's Hospital, Boston, United StatesKelan Tantisira7Department of Medicine, Brigham and Women's Hospital, Boston, United StatesColin Palmer2Population Pharmacogenetics Group, Biomedical Research Institute, University of Dundee, Ninewells Hospital and Medical School, Dundee, United KingdomAnke-Hilse Maitland-van der Zee1Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, Netherlands
- Is prematurity a risk factor for more severe childhood asthma?By Steve Turner, Anil Mehta, Jon Ayres, Colin Palmer and Somnath MukhopadhyaySteve Turner1Child Health, University of Aberdeen, Aberdeen, United KingdomAnil Mehta2Population Pharmacogenetics, University of Dundee, Dundee, United KingdomJon Ayres3Institute of Occupational and Environmental Medicine, University of Birmingham, Birmingham, United KingdomColin Palmer2Population Pharmacogenetics, University of Dundee, Dundee, United KingdomSomnath Mukhopadhyay4Academic Department of Paediatrics, Brighton and Sussex Medical School, Brighton, United Kingdom
- LSC 2013 abstract - ST13 and ORMDL3 polymorphisms affect the risk of exacerbations in steroid-treated asthmatic children and young adultsBy Susanne Vijverberg, Ellen Koster, Roger Tavendale, Maarten Leusink, Leo Koenderman, Jan Raaijmakers, Dirkje Postma, Gerard Koppelman, Steve Turner, Somnath Mukhopadhyay, Sze Man Tse, Kelan Tantisira, Colin Palmer and Anke-Hilse Maitland-van der ZeeSusanne Vijverberg1Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, Netherlands3Department of Respiratory Medicine, University Medical Centre Utrecht, Utrecht, NetherlandsEllen Koster1Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, NetherlandsRoger Tavendale2Population Pharmacogenetics Group, Biomedical Research Institute, University of Dundee, Ninewells Hospital and Medical School, Dundee, United KingdomMaarten Leusink1Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, NetherlandsLeo Koenderman3Department of Respiratory Medicine, University Medical Centre Utrecht, Utrecht, NetherlandsJan Raaijmakers1Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, NetherlandsDirkje Postma4Department of Pulmonology, Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center Groningen, Groningen, NetherlandsGerard Koppelman5Department of Paediatric Pulmonology and Paediatric Allergology, Beatrix Children's Hospital, Groningen Research Institute for Asthma and COPD, University of Groningen, University Medical Center, Groningen, NetherlandsSteve Turner6Department of Child Health, University of Aberdeen, Aberdeen, United KingdomSomnath Mukhopadhyay2Population Pharmacogenetics Group, Biomedical Research Institute, University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom8Department of Paediatrics, Royal Alexandra Children's Hospital, Brighton and Sussex Medical School, Brighton, United KingdomSze Man Tse7Department of Medicine, Brigham and Women's Hospital, Boston, United StatesKelan Tantisira7Department of Medicine, Brigham and Women's Hospital, Boston, United StatesColin Palmer2Population Pharmacogenetics Group, Biomedical Research Institute, University of Dundee, Ninewells Hospital and Medical School, Dundee, United KingdomAnke-Hilse Maitland-van der Zee1Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, Utrecht, Netherlands
- Interactions between antioxidant gene variants and dietary antioxidant intake for asthma outcomes in children – Food for thought?By Steve Turner, Jon Ayres, Colin Palmer, Anil Mehta, Somnath Mukhopadhyay and Graham DevereuxSteve Turner1Child Health, University of Aberdeen, Aberdeen, United KingdomJon Ayres2Occupational Medicine, University of Birmingham, Birmingham, United KingdomColin Palmer3Pharmacogenomics, University of Dundee, Dundee, United KingdomAnil Mehta3Pharmacogenomics, University of Dundee, Dundee, United KingdomSomnath Mukhopadhyay4Child Health, University of Brighton, Brighton, United KingdomGraham Devereux1Child Health, University of Aberdeen, Aberdeen, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.